ARS Pharmaceuticals(SPRY)
$3.95+0.38 (+10.64%)
SPRY
ARS Pharmaceuticals Revenue
$3.95
At close:+0.38 (+10.64%)
Want to see SPRY full AI Analyst Report?
ARS Pharmaceuticals (SPRY) Revenue
593 Followers
ARS Pharmaceuticals Revenue
ARS Pharmaceuticals had a revenue of 37.71M in the quarter ending Sep 30, 2026, with 12.04%. This bring the company's revenue in the last twelve months to 122.14M, Increased 4.45%. In the fiscal year ending Dec 31, 2025, ARS Pharmaceuticals had annual revenue of 84.28M with -5.46% growth.
- Revenue (ttm)
- 122.14M
- Revenue Growth
- -14.45%
- P/S Ratio
- 4.26
- Revenue/Employee
- $425,646
- Employees
- 198
- Market Cap
- $358.89M
Revenue Chart
ARS Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 84.28M | -4.87M | -5.46% |
| Dec 31, 2024 | 89.15M | 89.12M | 297063.33% |
| Dec 31, 2023 | 30.00K | -1.29M | -97.72% |
| Dec 31, 2022 | 1.32M | -4.19M | -76.10% |
| Mar 31, 2022 | 5.51M | -12.33M | -69.13% |
| Dec 31, 2020 | 17.84M | 17.84M | ― |
| Dec 31, 2019 | 0.00 | 0.00 | ― |
| Dec 31, 2018 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.